CLRB
Cellectar Biosciences, Inc.
$2.81
-0.02 (-0.71%)
At close · Jul 2
Market Cap
$22.46M
Shares
7,991,812
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.81
Open$2.85
Day$2.77–3.02
52W$2.20–6.52
Avg vol 30d153K
Short int57K · 0.7% float · 1.0d
Short vol75%
Last earningsMay 14, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−16% below
+
Price vs 50-day avg
+0% above
◦
RSI (14)
56 · neutral
+
MACD trend
positive
−
52-week position
14% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $3 › 200d $3 — 200d above 50d
−
Institutional flow
-5% holders QoQ · +4 funds added
+
Insider flow
Net +$50.0K over 90 days · 0% sells
+
Short interest
0.72% of float · ▼ -77.8% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
19 holders — near 1-yr low, contrarian setup
Fundamentals
Strong
+
EPS growth
+80% Y/Y
−
Free cash flow
$-23.1M
+
Balance sheet
net cash $12.9M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 14, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−16% below
Bearish
Price vs 50-day avg
+0% above
Bullish
RSI (14)
56 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
14% · near low
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Distributing
-5% holders QoQ · +4 funds added
Insider flow
Accumulating
Net +$50.0K over 90 days · 0% sells
Short interest
Falling
0.72% of float · ▼ -77.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
19 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $2
Now $3 · 14%
52-wk high $7
vs 200-day avg -16%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Disease control rate (DCR) | 98.2% | Phase 2b CLOVER WaM study | — |
| Major response rate (MRR) | 61.8% | Phase 2b CLOVER WaM study | — |
| Median duration of response (DoR) | 17.8 | Phase 2b CLOVER WaM study | — |
| Median progression-free survival (PFS) | 13.5 | Phase 2b CLOVER WaM study | — |
| Overall response rate (ORR) | 83.6% | Phase 2b CLOVER WaM study | — |
| Very good partial response/complete response rate (VGPR/CR) | 14.5% | Phase 2b CLOVER WaM study | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLRB
this stock
Cellectar Biosciences, Inc.
|
$22.46M | -4.7% | — | — | 0.7% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLRB | +13.8% | +8.1% | -15.1% | +1.1% | -4.8% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +12.3% | +9.3% | -23.1% | +1.4% | -14.0% |